FDA 483 - TriRx Huntsville Pharmaceutical Services, LLC - April 01, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
TriRx Huntsville Pharmaceutical Services, LLC, a drug product manufacturer in Huntsville, AL, was cited for significant deficiencies during an FDA inspection. The inspection revealed inadequate procedures to prevent objectionable microorganisms in drug products and a failure of the Quality Control Unit to properly investigate contamination sources and rejected materials. These issues indicate a serious lack of control over manufacturing processes and quality assurance.
ID · 3cc0cfca-da41-428e-b501-67cd70f9d2ae